Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell...

Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology...

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )

Latest developments in the treatment of mRCC

Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald

Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )

Long term response to apalutamide and other updates impacting patients with...

Prof Axel Merseburger and Prof Matthew Smith

Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )

mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early...

Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt...

mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early treatment? ( Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt Attard )

Diagnosis, testing and biomarkers in the individualisation of patient care with...

Prof Andrea Necchi and Prof Eva Compérat

Diagnosis, testing and biomarkers in the individualisation of patient care with FGFR mutated bladder cancer ( Prof Andrea Necchi and Prof Eva Compérat )

Nurse's perspective on PARP inhibitors and personalised medicine in prostate...

Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK

Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )

Updates on managing HER2-positive early breast cancer

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain

Updates on managing HER2-positive early breast cancer ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )

ASCO GU 2021: Renal cancer roundup

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

ASCO GU 2021: Renal cancer roundup ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

OncoAlert and ecancer weekly roundup for February 07 - 13, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for February 07 - 13, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

WCLC 2020 overview

Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA

WCLC 2020 overview ( Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA )

Emergence of PARP inhibitors in prostate cancer

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals...

Emergence of PARP inhibitors in prostate cancer ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )

Advances and treatment strategies for metastatic hormone-sensitive prostate...

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals...

Advances and treatment strategies for metastatic hormone-sensitive prostate cancer ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )

More from ecancer